… beta-lactamase (ESBL)-producing phenotype is frequent among Enterobacter isolates at the
Tel Aviv Sourasky Medical Center, Tel Aviv, … least one family of beta-lactamase genes in 11 …

… beta-lactamase (ESBL)-producing phenotype among Escherichia coli isolates in Tel Aviv is
12% (… All isolates produced various beta-lactamases with pIs ranging from 5.2 to 8.2, varying …

… Three studies were conducted at the Tel Aviv Medical Center, a 1100-bed tertiary hospital; …
The study protocol was approved by the ethics committee of the Tel Aviv Medical Center. …

… β-lactamases (ESBLs) has emerged as an important mechanism of resistance to β-lactam …
reduction in the MIC in the presence of a beta-lactamase inhibitor (9). Since these tests are …

… On the other hand, a group from Tel Aviv found that 60% of their ESBL-producing
Klebsiella sp. and 29% of ESBLproducing E. coli were resistant to piperacillin-tazobactam [10]. …

… of aminoglycosides, fluoroquinolones or beta-lactams/beta-lactamase inhibitors. Table 2, …
in Ra'anana and 15.2% and 8.4% in Tel Aviv. In a multilevel mixed effects model, the variables …

… Data on the relative efficacy of β-lactam/β-lactamase inhibitors (BL/BLIs) … Tigecycline in
vitro activity against extended spectrum β-lactamase … extended-spectrum beta lactamases …

… determined in the presence and absence of 2 μg/ml clavulanic acid or 0.4 mM EDTA to
determine the contribution to the resistance of class A and class B β-lactamases, respectively. …

… CREC isolates were multidrug resistant, all carried bla KPC-2 , and six of them were also
extended-spectrum beta-lactamase producers. Pulsed-field gel electrophoresis indicated six …

The aim of this study was to determine whether the route of extended-spectrum β-lactamase
(ESBL) transmission to hospitalized newborns was from their mothers during delivery. …